Global Transdermal Skin Patches Market Research Report to 2027 – Focus on Matrix, Multi-layer Drug-in-Adhesive, and Single-layer Drug-in-Adhesive – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Transdermal Skin Patches Market Research Report by Type (Matrix, Multi-layer Drug-in-Adhesive, and Single-layer Drug-in-Adhesive), Technology, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Transdermal Skin Patches Market size was estimated at USD 6,359.36 million in 2021, USD 7,380.04 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 16.22% to reach USD 15,676.78 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transdermal Skin Patches Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

 

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

 

The report answers questions such as:

1. What is the market size and forecast of the Global Transdermal Skin Patches Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transdermal Skin Patches Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transdermal Skin Patches Market?

4. What is the competitive strategic window for opportunities in the Global Transdermal Skin Patches Market?

5. What are the technology trends and regulatory frameworks in the Global Transdermal Skin Patches Market?

6. What is the market share of the leading vendors in the Global Transdermal Skin Patches Market?

7. What modes and strategic moves are considered suitable for entering the Global Transdermal Skin Patches Market?

 

Market Dynamics

Drivers

• Increased use in the treatment of migraine, cardiovascular diseases, and neurology disease
• Demand for a controlled drug release system to the patient
• Increasing number of smokers with rising initiatives to spread awareness about health impacts of smoking

Restraints

• Limitation of active substances that are absorbed through skin
• Inappropriate for high drug doses

Opportunities

• Growing funding and investments for drug development
• Government initiatives and increase in the number of partnerships

Challenges

• Varying adhesion with patch type and environmental conditions

Companies Mentioned

• 3M Company
• Abbott Laboratories, Limited
• Acrux Limited
• AdhexPharma
• ANI Pharmaceuticals Inc.
• Bayer AG
• Henan Lingrui Pharmaceutical Ltd
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Luye Pharma Group
• Medherant Limited
• Mylan NV (Viatris)
• Nitto Denko Corporation
• Novartis AG
• Purdue Pharma Manufacturing LP
• Samyang Biopharmaceuticals Corp.
• Tapemark Company
• Teikoku Pharma USA Inc.
• Tesa Labtec GmbH
• Teva Pharmaceutical Industries Ltd.

 

For more information about this report visit https://www.researchandmarkets.com/r/ts6y5r.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900